関連する実験動画
Updated: Jun 10, 2026

05:58
The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF
Published on: November 18, 2009
Plzfは,mTORC1に対抗することによって,生殖線祖先の自己更新を調節する
Robin M Hobbs1, Marco Seandel, Ilaria Falciatori
1Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Cell
|August 10, 2010
まとめ
過度に活発なmTORC1シグナリングは,ニッチ信号を妨害することによって幹細胞を枯渇させます. 転写因子Plzfは,精子原始細胞の再生に不可欠なmTORC1を阻害することによって,幹細胞プールを維持する.
科学分野:
- 細胞生物学 細胞生物学
- 幹細胞生物学 幹細胞生物学とは
- 生殖生物学 生殖生物学
背景:
- ラパミシン複合体1 (mTORC1) のメカニズム的標的の過活性は,幹細胞の枯渇と関連しています.
- mTORC1媒介性幹細胞喪失の背後にある正確なメカニズムは不明である.
- 精子幹細胞 (Spermatogonial progenitor cells,SPCs) は男性の生育に不可欠であり,幹細胞の維持を研究するモデルとして機能する.
研究 の 目的:
- SPCのメンテナンスにおけるmTORC1の役割を明らかにする.
- mTORC1シグナリングが幹細胞機能に影響を与える分子メカニズムを調査する.
- 幹細胞再生の文脈でmTORC1の活動を調節する要因を特定する.
主な方法:
- 精子原始細胞 (SPC) をモデルシステムとして利用した.
- Plzf欠乏がmTORC1活動とGDNFシグナル伝達に与える影響を調査した.
- mTORC1とGDNF受容体シグナリングの間の負のフィードバックループを分析しました.
主要な成果:
- mTORC1の過活性は,ニッチから派生した信号を干渉することによって,幹細胞の維持を損なう.
- Plzfが欠けているSPCでは,mTORC1の活性が強化されている.
- Plzf欠乏は,mTORC1媒介によるGDNF受容体への負のフィードバックにより,SPCにおけるGDNF応答を阻害する.
- Plzfは,mTORC1の阻害体であるRedd1を上調することでmTORC1の活性に抵抗する.
結論:
- mTORC1-Plzf相互作用は,精子幹細胞のプールを維持するための重要な調節剤として作用します.
- mTORC1とGDNF受容体を含む負のフィードバックメカニズムが,SPCの増殖と自己更新をバランスとします.
- この経路を理解することで,幹細胞の恒常性および生育保存のための潜在的な治療目標についての洞察が得られます.
関連する概念動画
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

